During induction, patients in the G-CSF group experienced a significant shortening in the duration of neutropenia (median 14 vs. 18 days, p < 0.001) and length of hospitalization (median 28 vs. 35 days, p < 0.001). The gene discussed is CSF3; the disease is neutropenia.